Nifedipine Tablet, Extended Release
Product Images NDC 67296-2170

This text provides information about Nifedipine Extended-Release Tablets, USP, with each film-coated tablet containing 30 mg of Nifedipine USP. The prescription medication should be swallowed whole, not divided, and stored in tight, light-resistant containers at specific temperatures to protect from light and moisture. The tablets are distributed by Aurobindo Pharma USA, Inc., and the package includes details like lot number, expiry date, and location of manufacture. Additional information includes dosage guidelines and the presence of color additives in the tablets.*

This text provides information about Nifedipine Extended-Release Tablets, each containing 60 mg of Nifedipine USP. It includes dosage guidance, a caution about FD&C Yellow No. 5 as a color additive, and instructions to swallow the tablets whole. The product is distributed by Aurobindo Pharma USA, Inc. and should be stored in light-resistant containers at 20° to 25°C. The company address is given as 279 Princeton-Hightstown Road, East Windsor, NJ. Pharmacies are instructed to dispense the tablets as prescribed and to protect them from light and moisture. The text also mentions a code and other details for tracking and packaging purposes.*

This text is a detailed description of Nifedipine Extended-Release Tablets, USP (90 mg strength) by Aurobindo Pharma USA, Inc. The tablets are film-coated and come in a pack of 100 tablets. It provides instructions to swallow the tablets whole and not to bite or divide them. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with permissible excursions to 15°C to 30°C (59°F to 86°F). It also mentions that the tablets should be dispensed in tight, light-resistant containers and should be protected from light and moisture. The contact information for Aurobindo Pharma USA, Inc. and the manufacturing details in India are also included.*